The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

The FDA has approved Onapgo, the first subcutaneous apomorphine device to treat motor fluctuations in adults with Parkinson’s disease, according to the manufacturer.In a press release, Supernus ...

This free automatic tax filing service will be offered to “individuals with low or fixed incomes and simple tax situations that remain unchanged from year to year,” Déborah Cléry ...

Rotating can help reduce pain when ongoing injections are needed. It may also reduce the risk of tissue scarring. Subcutaneous injections are those delivered in the fatty tissue that lies between the ...

Botox can cause side effects that range from mild to serious. Examples include headache, injection site reactions, and urinary retention. If side effects from Botox become difficult to tolerate ...

Benzinga readers often choose 3Commas as the best automated trading software. What if you could take the psychological element out of trading? What if you could trade without becoming a victim of ...

Michael Adams is a former Cryptocurrency and Investing Expert Editor at Forbes Advisor. He's researched, written about and practiced investing for nearly two decades. As a writer, Michael has ...

Side effects of biologic drugs may include: respiratory infections headaches flu-like symptoms swelling, itching, or a rash at the injection site urinary tract infection Two types of biologic ...

Instead, he listed them on iPads handed to patients after they arrived, and instructed his employees never to take pictures of him performing injections, prosecutors said. When clients complained ...

and other companies that have rolled out automated driver features in recent years. The regulator's analysis will determine if a safety recall is necessary and could help influence the development ...

That could soon change. Eisai, the company that makes Leqembi, said it asked the Food and Drug Administration (FDA) to approve a version of the drug that is given as a subcutaneous injection—a shot ...